IP Library Granted Patent US 11,141,585
Granted Patent B2
US 11,141,585 · App. 16/235,634 · Granted Oct 12, 2021

Non-invasive neural interface

Inventor: Krishnan Thyagarajan (Mountain View, CA)
Assignee: Palo Alto Research Center Incorporated
A61N1/323A61B5/4836A61B5/6801A61B5/6867A61N1/40A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,585
App. No.
16/235,634
Granted
Oct 12, 2021
Kind
B2
Abstract

A neuromodulator includes an electromagnetic (EM) wave generator configured to generate EM waves remote from a patient and to direct the EM waves to one or more target regions within the patient. Frequencies of the EM waves fall outside a range of frequencies that activates neurons. Intersection of the EM waves in each target region creates envelope-modulated electric and magnetic fields having one or more frequencies that fall within the range of frequencies that activates neurons. The neuromodulator includes control circuitry configured to control parameters of the EM waves produced by the EM wave generator. The neuromodulator may use feedback based on one or more of patient input and/or sensing of physiological signals in order to close the loop and control the EM waves.

Claims (37)

1. A system, comprising:

a neuromodulator comprising:

an electromagnetic (EM) wave generator configured to generate EM waves remote from a patient and to direct the EM waves to one or more target regions within the patient, frequencies of the EM waves falling outside a range of frequencies that activates neurons, intersection of the EM waves in each target region creating envelope-modulated electric and magnetic fields having one or more frequencies that fall within the range of frequencies that activates neurons; and

control circuitry configured to control one or more parameters of the EM waves produced by the EM wave generator;

wherein the frequencies of the EM waves are greater than about 150 kHz and frequencies of the envelope-modulated electric and magnetic fields are less than about 100 kHz.

2. The system of claim 1 , wherein the control circuitry is configured to control the one or more parameters of the EM waves to change one or more characteristics of the envelope-modulated electrical and magnetic fields in the target regions.

3. The system of claim 2 , wherein:

the one or more parameters that change the characteristics of the envelope-modulated electrical and magnetic fields include frequency, phase, and amplitude; and

the one or more characteristics of the envelope-modulated electrical and magnetic fields include frequency, amplitude, and modulation depth.

4. The system of claim 1 , wherein:

the EM wave generator comprises a phased array configured to generate multiple EM waves; and

the control circuitry is configured to control one or more parameters of the multiple EM waves such that the multiple EM waves undergo constructive and destructive interference that focuses and/or steers the multiple EM waves to the target regions.

5. The system of claim 1 , wherein an amplitude of the envelope modulated electric field exceeds a threshold for neural activation.

6. The system of claim 1 , wherein an amplitude of the envelope modulated electric field is below a threshold for activation of neurons within the target region.

7. The system of claim 1 , wherein a minimum volume in which neurons are activated by the neuromodulation device without activating neurons outside the volume is less than about 125 cm 3 .

8. The system of claim 1 , wherein a maximum amplitude of the envelope modulated electric field falls within the target region.

9. The system of claim 1 , further comprising communications circuitry configured to transfer patient information from an additional device to the neuromodulation device; and

wherein the control circuitry is configured to modify one or more parameters of at least one of the first and second EM waves based on the patient information.

10. The system of claim 9 , wherein the patient information comprises sensed physiological signals.

11. The system of claim 9 , wherein the patient information are based on patient-provided input.

12. The system of claim 1 , further comprising a receiver configured to receive EM waves modulated by a neural activity signal generated by neural activity within the target region.

13. The system of claim 12 , wherein the control circuitry is configured to:

extract the neural activity signal from the EM waves modulated by the neural activity signal; and

control the one or more parameters of the EM waves based on the neural activity signal.

14. A method, comprising:

generating electromagnetic (EM) waves at a location remote from a patient, frequencies of the EM waves falling outside a range of frequencies that activate neurons;

directing the EM waves to one or more target region within the patient; and

intersecting the EM waves in the target regions, in each target region, intersection of the EM waves creating envelope-modulated electrical and magnetic fields having frequencies falling within the range of frequencies that activate neurons.

wherein the frequencies of the EM waves are greater than about 150 kHz and frequencies of the envelope-modulated electric and magnetic fields are less than about 100 kHz.

15. The method of claim 14 , further comprising controlling one or more parameters of the first and second EM waves to change one or more characteristics of the envelope-modulated electrical and magnetic fields in the target regions.

16. The method of claim 14 , further comprising receiving EM waves modulated by a neural activity signal generated by neural activity within the target region.

17. The method of claim 16 , further comprising modifying parameters of the first and second EM waves based on the EM wave modulated by neural activity signal.

18. The method of claim 14 , further comprising modifying parameters of the first and second EM waves based on patient information transferred from an additional device.

19. The method of claim 18 , wherein the additional device is a physiological sensor implanted within or attached to the patient.

20. The method of claim 18 , wherein:

the additional device includes a user interface that allows the patient to input the patient information; and

modifying the parameters comprises modifying the parameters based on information input by the patient.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073562/0677 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2018
From: THYAGARAJAN, KRISHNAN
To: PALO ALTO RESEARCH CENTER INCORPORATED
Reel/Frame 047871/0142 →
Continuity (1)
Related Publication 20200206497A1 · Jul 2, 2020